Close Menu

The story has been updated to clarify language about Cancer Genetics' review of its operations.  

NEW YORK (GenomeWeb) – At least two class action lawsuits have been filed against Cancer Genetics alleging the company made false and/or misleading statements and/or failed to disclose information pertinent to investors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.